A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of PDC-1421 Capsule in healthy subject,
find the effective adequate dose for the next stage of the study, and accumulate information
of possible mechanism of its anti-depressive effect.